News

MUSC Health becomes first on East Coast to put under-the-skin cochlear implant in patient in national clinical trial of innovative device.

“There's an incredible amount of excitement about this device.” MUSC prepares to place totally under-the-skin cochlear implants in patients with hearing loss.

Hollings researcher receives Department of Defense Early Career Scholar Award to improve immune therapies by targeting resistant kidney tumors.

Precision Health Research Symposium at MUSC highlights experts’ insights about changes that will transform preventive health care and improve health equity.

Blue Sky Labs, incubation space for start-ups and early-stage companies focusing on life sciences and medical research, opens at MUSC.

An international collaboration has advanced therapies for co-occurring substance use disorders and PTSD and helped to inform prevention efforts globally.

Using a novel model for a common fatty liver disease, an MUSC team has identified a pathway that could be targeted to reduce fat accumulation in the liver.

MUSC Hollings researchers find that targeting an immunosuppressive protein on two fronts can reduce metastasis and restore sensitivity to immunotherapy.

The CREW program encourages early-career women in science to become entrepreneurs.

Polyploid giant cancer cells, which are monstrously oversized and contain multiple nuclei, could be culprits in disease recurrence after cancer therapy.